Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Net Income: 2022-2025

Historic Net Income for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to -$8.2 million.

  • InMed Pharmaceuticals' Net Income fell 2.92% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.2 million, marking a year-over-year decrease of 20.58%. This contributed to the annual value of -$8.2 million for FY2025, which is 6.34% down from last year.
  • As of FY2025, InMed Pharmaceuticals' Net Income stood at -$8.2 million, which was down 6.34% from -$7.7 million recorded in FY2024.
  • InMed Pharmaceuticals' Net Income's 5-year high stood at -$7.7 million during FY2024, with a 5-year trough of -$18.6 million in FY2022.
  • Over the past 3 years, InMed Pharmaceuticals' median Net Income value was -$7.9 million (recorded in 2023), while the average stood at -$7.9 million.
  • As far as peak fluctuations go, InMed Pharmaceuticals' Net Income soared by 57.27% in 2023, and later declined by 6.34% in 2025.
  • Over the past 4 years, InMed Pharmaceuticals' Net Income (Yearly) stood at -$18.6 million in 2022, then skyrocketed by 57.27% to -$7.9 million in 2023, then rose by 3.42% to -$7.7 million in 2024, then declined by 6.34% to -$8.2 million in 2025.